Witt, S. ; Krauss, E.* ; Barbero, M.A.N.* ; Müller, V.* ; Bonniaud, P.* ; Vancheri, C.* ; Wells, A.U.* ; Vasakova, M.* ; Pesci, A.* ; Klepetko, W.* ; Seeger, W.* ; Crestani, B.* ; Leidl, R. ; Holle, R. ; Schwarzkopf, L. ; Guenther, A.*
Psychometric properties and minimal important differences of SF-36 in Idiopathic Pulmonary Fibrosis.
Respir. Res. 20:47 (2019)
Background: Idiopathic pulmonary fibrosis (IPF) is a rare disease with a median survival of 3-5 years after diagnosis with limited treatment options. The aim of this study is to assess the psychometric characteristics of the Short Form 36 Health Status Questionnaire (SF-36) in IPF and to provide disease specific minimally important differences (MID). Methods: Data source was the European IPF Registry (eurIPFreg). The psychometric properties of the SF-36 version 2 were evaluated based on objective clinical measures as well as subjective perception. We analysed acceptance, feasibility, discrimination ability, construct and criterion validity, responsiveness and test-retest-reliability. MIDs were estimated via distribution and anchor-based approaches. Results: The study population included 258 individuals (73.3% male; mean age 67.3 years, SD 10.7). Of them 75.2% (194 individuals) had no missing item. The distribution of several items was skewed, although floor effect was acceptable. Physical component score (PCS) correlated significantly and moderately with several anchors, whereas the correlations of mental component score (MCS) and anchors were only small. The tests showed mainly significant lower HRQL in individuals with long-term oxygen therapy. Analyses in stable individuals did not show significant changes of HRQL except for one dimension and anchor. Individuals with relevant changes of the health status based on the anchors had significant changes in all SF-36 dimensions and summary scales except for the dimension PAIN. PCS and MCS had mean MIDs of five and six, respectively. Mean MIDs of the dimensions ranged from seven to 21. Conclusion: It seems that the SF-36 is a valid instrument to measure HRQL in IPF and so can be used in RCTs or individual monitoring of disease. Nevertheless, the additional evaluation of longitudinal aspects and MIDs can be recommended to further analyse these factors. Our findings have a great potential impact on the evaluation of IPF patients. Trial registration: The eurIPFreg and eurIPFbank are listed in https://clinicaltrials.gov (NCT02951416).
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Idiopathic Pulmonary Fibrosis ; Patient-reported Outcome ; Quality Of Life ; Rare Diseases; Quality-of-life; German Guideline; Controlled-trial; Diagnosis; Validation; Management; 6-minute; Bosentan; Dyspnea; Update
Keywords plus
Language
english
Publication Year
2019
Prepublished in Year
HGF-reported in Year
2019
ISSN (print) / ISBN
1465-9921
e-ISSN
1465-993X
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 20,
Issue: 1,
Pages: ,
Article Number: 47
Supplement: ,
Series
Publisher
BioMed Central
Publishing Place
Campus, 4 Crinan St, London N1 9xw, England
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
80000 - German Center for Lung Research
30202 - Environmental Health
Research field(s)
Genetics and Epidemiology
PSP Element(s)
G-501800-533
G-505300-001
G-505300-002
Grants
Copyright
Erfassungsdatum
2019-03-21